Anuncio
Anuncio

VRTX

VRTX logo

Vertex Pharmaceuticals Inc

442.96
USD
Patrocinado
-3.87
-0.87%
08 jun, 16:00 UTC -4
Cerrado
exchange

Post-mercado

442.82

-0.13
-0.03%

Panorámica financiera de Vertex Pharmaceuticals Inc

Cap. de Mercado
112.39B
Beta
0.36
Beneficios Por Acción (BPA)
15.33
Ratio Precio/Valor (P/V) Contable
6.07
Margen de explotación
35.26%
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
27.21
Rentabilidad sobre recursos propios (ROE)
24.30%
Ratio de liquidez
2.90%
Flujo de caja libre
3.19B
Perfil de VRTX

Gráfico de Beneficios

Beneficios de VRTX

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$949.28
+9.87%
Nvidia Corp logo
Nvidia Corp$208.64
+1.73%
Marvell Technology, Inc. Common Stock logo
Marvell Technology, Inc. Common Stock$288.85
+9.63%
Apple Inc. logo
Apple Inc.$301.54
-1.89%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$408.95
+4.59%
Intel Corp logo
Intel Corp$110.27
+11.19%
Broadcom Inc. Common Stock logo
Broadcom Inc. Common Stock$396.60
+2.82%
Anuncio